The Valley Desk

NCT06691984 · Interventional trial

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Overall registry status Active not recruiting

Phase 3

Conditions Metastatic Castration-resistant Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov